Warbicin
Pre-clinical- Indications
- Cancer
Company intelligence / Profile preview
NovelYeast develops and commercializes advanced engineered yeast strains for a wide range of industrial applications including the production of biofuels (ethanol, isobutanol), specialty sugars and sweeteners, single-cell protein, alcoholic beverages, nutraceuticals, probiotics, flavor compounds and plastic recycling. The company’s technology enables on-site enzyme generation for efficient conversion of lignocellulosic biomass as well as upcycling food industry by-products into value-added ingredients. It also offers R&D services in yeast biotechnology. No clinical results apply since the company operates outside human therapeutics.[1][2][5][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovelYeast.